Is Aging Driven by Declining Glycolysis?

A new perspective—and how mitochondrial mechanics may reconcile the debate.

A recent perspective published in AGING proposes a provocative idea: aging may be fundamentally driven by a gradual decline in glycolytic ATP production. The authors argue that many aging phenotypes—from impaired tissue repair to neurodegeneration—could arise because cells progressively lose their ability to generate ATP rapidly through glycolysis.

It is a bold proposal, and it touches a key question in biology:

Does aging occur because energy production systems fail?

However, when we examine the broader literature, the story appears more complex. Evidence exists suggesting that aging is associated both with increased glycolysis and with declining glycolysis, depending on context.

Understanding why these seemingly contradictory observations exist may require a different framework—one that considers how cells dynamically adapt to bioenergetic stress.

This is where the ERM mitochondrial mechanics framework may help clarify the picture.

The Perspective: Aging as a Decline in Glycolytic ATP

The perspective proposes several key ideas:

1. Glycolysis produces ATP extremely rapidly—much faster than oxidative phosphorylation.

2. Glycolytic ATP supports processes that require rapid energy supply, such as:

   • cell division

   • DNA repair

   • mitochondrial quality control (mitophagy).

3. If glycolytic ATP production declines with age, these processes would gradually fail, leading to aging phenotypes.

The authors also suggest an evolutionary explanation: species may have evolved a gradual decline in glycolysis over time as a trade-off that optimizes survival and reproduction.

At first glance, this seems plausible. But when we look at the broader evidence, we find a

more nuanced picture.

Evidence That Aging Is Associated With Increased Glycolysis

At the cellular level, many aging-related processes actually show a shift toward glycolysis, not away from it.

Senescent cells

Cells that enter cellular senescence—a hallmark of aging—often exhibit a metabolic pattern similar to the “Warburg effect” seen in cancer:

• increased glycolysis

• increased lactate production

• altered mitochondrial metabolism

This shift appears to help cells maintain ATP production despite mitochondrial dysfunction.

In other words, glycolysis may increase as a compensatory mechanism when mitochondria are stressed.

Stress and immune activation

Activated immune cells and inflammatory states—common features of aging—also show:

• increased glycolysis

• metabolic reprogramming toward rapid ATP generation.

Again, this pattern suggests compensation, not decline.

Evidence That Aging Is Associated With Declining Glycolysis

At the organ and tissue level, however, the opposite pattern often appears.

Brain aging

Brain imaging studies using FDG-PET consistently show:

• Reduced glucose metabolism with age

• progressive decline in conditions such as Alzheimer’s disease.

  
  

This is one of the most robust metabolic signatures of brain aging.

Skeletal muscle aging

With aging, skeletal muscle often undergoes:

• loss of fast-twitch glycolytic fibers

• reduced glycolytic capacity.

This contributes to sarcopenia and metabolic dysfunction.

Immune aging

Some aging immune cells exhibit metabolic exhaustion, with reduced capacity for both:

• glycolysis

• oxidative phosphorylation.

Why the Literature Looks Contradictory

These findings appear contradictory only if we assume aging follows a single metabolic trajectory.

But biology rarely works that way.

The key distinction may be the stage.

Early responses to metabolic stress may increase glycolysis.

Later stages may show declining metabolic capacity.

This is where the ERM framework offers a useful lens.

ERM Mitochondrial Mechanics: A Dynamic Energy Model

The ERM framework proposes that many chronic diseases and aging phenotypes arise from limitations in mitochondrial throughput—the capacity of mitochondria to process metabolic substrates and maintain redox balance.

In this model, aging progresses through stages of metabolic adaptation.

Stage 1 — Compensation

When mitochondrial throughput becomes constrained:

• NADH accumulates

• Oxidative phosphorylation slows

• ATP demand remains high.

Cells respond by increasing glycolysis to maintain ATP supply.

This stage may produce:

• lactate elevation

• glycolytic bias

• Warburg-like metabolic shifts.

Stage 2 — Persistent congestion

If mitochondrial stress continues:

• Redox imbalance persists

• ATP reserves decline

• Metabolic flexibility decreases.

Cells increasingly rely on glycolysis, but the system is under strain.

Stage 3 — Decompensation / exhaustion

Eventually, compensatory mechanisms fail.

At this stage, we may observe:

• declining glycolytic capacity

• impaired glucose utilization

• systemic energy deficit.

This stage aligns with observations such as:

• declining brain glucose metabolism

• metabolic exhaustion in aging tissues.

Reconciling the Two Views

The perspective suggests:

declining glycolysis → aging

The ERM model proposes a different sequence:

mitochondrial throughput constraint→ glycolytic compensation→ energetic exhaustion

→ declining glycolysis

In this interpretation, declining glycolysis is not the initial cause of aging but the final stage of metabolic failure.

Both observations can therefore be true.

They simply reflect different stages of the same process.

Why This Matters

Understanding the sequence of metabolic changes is critical for designing effective interventions.

If aging begins with mitochondrial throughput constraints, then therapies should focus on:

• improving mitochondrial function

• restoring redox balance

• expanding bioenergetic capacity.

Simply increasing glycolysis may offer temporary relief, but it may not address the underlying constraint.

A Unifying Perspective

The recent perspective highlights an important observation:

Glycolysis is deeply connected to cellular repair and regeneration.

But rather than being the root cause of aging, glycolytic decline may represent the final stage of prolonged bioenergetic stress.

In this way, the study contributes valuable observations that may ultimately support a staged model of aging metabolism, where early compensation gradually gives way to systemic exhaustion.

The Takeaway

Aging metabolism may not follow a single linear trajectory.

Instead, the emerging evidence suggests a dynamic progression:

1. Early stage: glycolysis increases to compensate for mitochondrial stress

2. Intermediate stage: persistent metabolic congestion develops

3. Late stage: both mitochondrial and glycolytic energy systems decline

The ERM mitochondrial mechanics framework attempts to capture this progression.

And perspectives like this new paper help push the field toward a deeper question:

Is aging ultimately a story of energy allocation—and the limits of biological resilience?

Taguchi, A., Okinaka, Y., Claussen, C., & Gul, S. (2026). A decline in glycolytic ATP production is the fundamental mechanism limiting lifespan; species with an optimal rate of decline over time survived. Aging (Albany NY), 18. https://doi.org/10.18632/aging.206302